肝细胞癌的Glypican-3向免疫oPET成像:一个翻译性研究
Zhaoguo Lin1,2,3, Wenzhu Hu1,2,3, Mengting Li1,2,3
1Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, Hubei Province, 430022, China.
European journal of nuclear medicine and molecular imaging
|February 13, 2026
概括
一种针对Glypican-3 (GPC3) 的新型-68标记的标记物有效地可视化了患者的肝细胞癌 (HCC). 这种针对GPC3的immunoPET追踪器显示出改善HCC诊断和检测小病变的前景.
科学领域:
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
- 分子成像学分子成像学
背景情况:
- 准确的肝细胞癌 (HCC) 诊断是一项挑战.
- 格利皮坎-3 (GPC3) 是一种有前途的生物标志物,在HCC中高度表达.
- 基于PET的分子成像为增强HCC检测提供了潜在的潜力.
研究的目的:
- 开发一种新的针对GPC3的免疫oPET放射追踪器.
- 评估该标记物在HCC患者中的临床可行性和安全性.
- 评估其在HCC中GPC3表达的非侵入性可视化能力.
主要方法:
- 合成并描述了加-68标记的抗GPC3片段 (Ga-aGPC3-Fab).
- 进行了体外和小动物PET/CT研究,用于GPC3向验证.
- 进行了第一个在人体上的试点研究,其中有五名HCC患者接受了Ga-aGPC3-Fab PET成像.
主要成果:
- [68Ga]Ga-aGPC3-Fab表现出高放射性化学纯度,强烈的GPC3亲和力,以及高效的细胞内化.
- 在临床前模型中,追踪器能够清晰可视化GPC3阳性HCC瘤.
- 在患者中,Ga-aGPC3-Fab检测到小的肝脏内转移 (约. 1厘米) 具有高对比度,包括MRI遗漏的病变,并显示出良好的安全性.
结论:
- [68Ga]Ga-aGPC3-Fab是一种安全有效的PET追踪器,用于可视化GPC3阳性HCC病变.
- 这种新型的放射追踪器显示了提高HCC的诊断准确性的潜力.
- 它可以作为传统成像模式的宝贵补充工具.
相关概念视频
01:31Translation
157.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.4K
01:31Translation
18.2K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
18.2K
02:33Initiation of Translation
39.3K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.3K
01:44Termination of Translation
28.0K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
28.0K
01:44Termination of Translation
6.8K
6.8K
02:07Improving Translational Accuracy
15.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.1K